By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Bellicum Pharmaceuticals, Inc. 

2 Greenway Plaza
Suite 1380
Houston  Texas  77046  U.S.A.
Phone: 713-798-8670 Fax: 713-798-4950


SEARCH JOBS



Segment
Vaccines





Company News
Bellicum Pharmaceuticals, Inc. To Present At Jefferies and Co. 2014 Global Healthcare Conference In New York City 6/3/2014 7:11:03 AM
Bellicum Pharmaceuticals, Inc. To Present At Jefferies and Co. 2014 Global Healthcare Conference In New York City 6/3/2014 6:55:26 AM
Bellicum Pharmaceuticals, Inc. Hauls In $34.4 Million Series B Financing 1/7/2014 6:46:04 AM
Bellicum Pharmaceuticals, Inc. Initiates Clinical Trial With Novel Controlled Dendritic Cell Immunotherapy in Metastatic Castrate Resistant Prostate Cancer 7/9/2013 9:43:52 AM
Bellicum Pharmaceuticals, Inc. Selects DATATRAK International, Inc. (DATA) Solution for Drug Program 9/12/2012 10:46:37 AM
Bellicum Pharmaceuticals, Inc. Appoints Baylor College of Medicine's David M. Spencer as Chief Scientific Officer 4/12/2012 10:28:11 AM
Bellicum Pharmaceuticals, Inc. Closes $20 Million Series B Financing 3/8/2012 7:34:06 AM
Bellicum Pharmaceuticals, Inc. Announces Publication in The New England Journal of Medicine Demonstrating Complete Reversal of Serious Immune Condition in Hematopoietic Stem Cell Transplant Patients 11/3/2011 10:39:35 AM
Bellicum Pharmaceuticals, Inc. Awarded $5.7 Million by the Cancer Prevention and Research Institute of Texas 3/25/2011 6:43:19 AM
Bellicum Pharmaceuticals, Inc. Release: Clinical Responses Demonstrated in Metastatic Castrate Resistant Prostate Cancer Patients Treated With BPX-101 Cancer Vaccine in Phase I/II Study 2/18/2011 6:25:22 AM
12
//-->